Cargando…

Exosomal MicroRNA Levels Associated with Immune Checkpoint Inhibitor Therapy in Clear Cell Renal Cell Carcinoma

Immunotherapy with immune checkpoint inhibitors (ICIs) has shown high efficiency in clear cell renal cell carcinoma (ccRCC) treatment. However, the response to therapy among patients varies greatly. Modern studies demonstrate the high potential of exosomal miRNAs as diagnostic and prognostic markers...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ivanova, Elizaveta, Asadullina, Dilara, Gilyazova, Gulshat, Rakhimov, Radmir, Izmailov, Adel, Pavlov, Valentin, Khusnutdinova, Elza, Gilyazova, Irina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045368/ https://www.ncbi.nlm.nih.gov/pubmed/36979782 http://dx.doi.org/10.3390/biomedicines11030801

Ejemplares similares

Exosomal miRNA-155 and miRNA-146a are promising prognostic biomarkers of the severity of hemorrhagic fever with renal syndrome
por: Gilyazova, Irina, et al.
Publicado: (2022)

Exosomal miRNA-146a is downregulated in clear cell renal cell carcinoma patients with severe immune-related adverse events
por: Ivanova, E., et al.
Publicado: (2022)

MicroRNA Expression Signatures in Clear Cell Renal Cell Carcinoma: High-Throughput Searching for Key miRNA Markers in Patients from the Volga-Ural Region of Eurasian Continent
por: Gilyazova, Irina, et al.
Publicado: (2023)

MicroRNA Processing Pathway-Based Polygenic Score for Clear Cell Renal Cell Carcinoma in the Volga-Ural Region Populations of Eurasian Continent
por: Ivanova, Elizaveta, et al.
Publicado: (2022)

miRNA Expression Patterns in Early- and Late-Stage Prostate Cancer Patients: High-Throughput Analysis
por: Gilyazova, Irina, et al.
Publicado: (2023)

MiRNA-146a—A Key Player in Immunity and Diseases
por: Gilyazova, Irina, et al.
Publicado: (2023)

Epigenetic and Immunological Features of Bladder Cancer
por: Gilyazova, Irina, et al.
Publicado: (2023)

The potential of miR-153 as aggressive prostate cancer biomarker
por: Gilyazova, Irina, et al.
Publicado: (2022)

Prostate Cancer: Genetics, Epigenetics and the Need for Immunological Biomarkers
por: Rafikova, Guzel, et al.
Publicado: (2023)

COVID-19: Mechanisms, risk factors, genetics, non-coding RNAs and neurologic impairments
por: Gilyazova, Irina, et al.
Publicado: (2023)

Analysis of Gene Expression and Neuronal Phenotype in Neuroscreen-1 (NS-1) Cells
por: Pokharel, Smritee, et al.
Publicado: (2018)

B355252, A Novel Small Molecule, Confers Neuroprotection Against Cobalt Chloride Toxicity In Mouse Hippocampal Cells Through Altering Mitochondrial Dynamics And Limiting Autophagy Induction
por: Chimeh, Uchechukwu, et al.
Publicado: (2018)

A Rapid, Inexpensive High Throughput Screen Method for Neurite Outgrowth
por: Yeyeodu, Susan T, et al.
Publicado: (2010)

Exosomal MicroRNA as Biomarkers for Diagnosing or Monitoring the Progression of Ovarian Clear Cell Carcinoma: A Pilot Study
por: Horie, Kayo, et al.
Publicado: (2022)

The Role of Long Non-Coding RNAs in Intracranial Aneurysms and Subarachnoid Hemorrhage
por: Gareev, Ilgiz, et al.
Publicado: (2020)

Management strategy for cancer patients in the context of the COVID-19 epidemic
por: Izmailov, Adel, et al.
Publicado: (2020)

Exosomal microRNAs in cancer: Potential biomarkers and immunotherapeutic targets for immune checkpoint molecules
por: Alotaibi, Faizah
Publicado: (2023)

Expression and Significance of Immune Checkpoints in Clear Cell Carcinoma of the Uterine Cervix
por: Zong, Liju, et al.
Publicado: (2020)

Immune Checkpoint Inhibition in Advanced Non-Clear Cell Renal Cell Carcinoma: Leveraging Success from Clear Cell Histology into New Opportunities
por: Zarrabi, Kevin, et al.
Publicado: (2021)

Perspective for Studying the Relationship of miRNAs with Transposable Elements
por: Mustafin, Rustam Nailevich, et al.
Publicado: (2023)

A Contemporary Review of Immune Checkpoint Inhibitors in Advanced Clear Cell Renal Cell Carcinoma
por: Yu, Eun-mi, et al.
Publicado: (2021)

Circulating exosomal mRNA signatures for the early diagnosis of clear cell renal cell carcinoma
por: He, Xing, et al.
Publicado: (2022)

Oncogenic MicroRNAs Characterization in Clear Cell Renal Cell Carcinoma
por: Petrozza, Vincenzo, et al.
Publicado: (2015)

Imaging of Clear Cell Renal Carcinoma with Immune Checkpoint Targeting Aptamer-Based Probe
por: Malicki, Stanisław, et al.
Publicado: (2022)

A Systematic Review of Immune Checkpoint Inhibitors in Non-Clear-Cell Renal Cancer
por: Palma dos Reis, Ana Filipa, et al.
Publicado: (2022)

Aggregation, Cytotoxicity and DNA Binding in a Series of Calix[4]arene Amphiphile Containing Aminotriazole Groups
por: Mironova, Diana, et al.
Publicado: (2023)

Decasubstituted Pillar[5]arene Derivatives Containing L-Tryptophan and L-Phenylalanine Residues: Non-Covalent Binding and Release of Fluorescein from Nanoparticles
por: Sultanaev, Vildan, et al.
Publicado: (2023)

Eosinophilic features in clear cell renal cell carcinoma correlate with outcomes of immune checkpoint and angiogenesis blockade
por: Yoshida, Takashi, et al.
Publicado: (2021)

A Novel Ferroptosis-Related Pathway for Regulating Immune Checkpoints in Clear Cell Renal Cell Carcinoma
por: Gao, Su, et al.
Publicado: (2021)

Metastatic Clear-Cell Renal Cell Carcinoma in the Era of Immune Checkpoint Inhibitors: Therapies and Ongoing Trials
por: Zhuang, Tony Zibo, et al.
Publicado: (2022)

Construction and Validation of a Novel Immune Checkpoint-Related Model in Clear Cell Renal Cell Carcinoma
por: Fan, ZhiXiang, et al.
Publicado: (2022)

Fat Loss in Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors
por: Lee, Ji Hyun, et al.
Publicado: (2023)

Role of tumor-derived exosomes in metastasis, drug resistance and diagnosis of clear cell renal cell carcinoma
por: Jiang, Tiancheng, et al.
Publicado: (2022)

MicroRNAs in clear cell renal cell carcinoma: biological functions and applications
por: Aguiari, Gianluca
Publicado: (2015)

MicroRNA Profiling of Morphologically Heterogeneous Clear Cell Renal Cell Carcinoma
por: Giubellino, Alessio, et al.
Publicado: (2021)

Identification of microRNA editing sites in clear cell renal cell carcinoma
por: Liu, Yulong, et al.
Publicado: (2023)

Role of exosomes and exosomal microRNAs in cancer
por: Dilsiz, Nihat
Publicado: (2020)

The roles of exosomal immune checkpoint proteins in tumors
por: Xing, Cheng, et al.
Publicado: (2021)

Identification of the Prognosis Value and Potential Mechanism of Immune Checkpoints in Renal Clear Cell Carcinoma Microenvironment
por: Liao, Guodong, et al.
Publicado: (2021)

Negative regulation of tumor-infiltrating NK cell in clear cell renal cell carcinoma patients through the exosomal pathway
por: Xia, Yang, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ijha1pi2bfjnsn2di2bdpe11dj